NASDAQ:CLBT - Cellebrite DI Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $11.50
  • Forecasted Upside: 152.19 %
  • Number of Analysts: 7
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 7 Buy Ratings
  • 0 Strong Buy Ratings
$4.56
▼ -0.06 (-1.30%)

This chart shows the closing price for CLBT by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Cellebrite DI Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for CLBT and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for CLBT

Analyst Price Target is $11.50
▲ +152.19% Upside Potential
This price target is based on 7 analysts offering 12 month price targets for Cellebrite DI in the last 3 months. The average price target is $11.50, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 152.19% upside from the last price of $4.56.

This chart shows the closing price for CLBT for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 7 investment analysts is to buy stock in Cellebrite DI.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
12/2/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
3/2/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/31/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/29/2021
  • 0 strong buy ratings
  • 4 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/27/2021
  • 0 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/25/2022
  • 0 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 0 sell ratings
4/26/2022
  • 0 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/26/2022

Latest Recommendations

  • 0 strong buy ratings
  • 7 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/16/2022CowenLower Price Target$17.00 ➝ $13.00High
5/13/2022Deutsche Bank AktiengesellschaftLower Price Target$11.00 ➝ $10.00High
2/24/2022JPMorgan Chase & Co.Initiated CoverageOverweight$10.50High
2/17/2022CowenLower Price Target$20.00 ➝ $17.00Low
2/17/2022Deutsche Bank AktiengesellschaftBoost Price Target$10.50 ➝ $11.00Medium
2/11/2022Deutsche Bank AktiengesellschaftInitiated CoverageBuy$10.50Low
12/29/2021Needham & Company LLCLower Price TargetBuy$12.00 ➝ $9.50High
12/2/2021Bank of AmericaInitiated CoverageBuy$11.00High
10/20/2021CitigroupInitiated CoverageBuy$15.00High
9/29/2021Needham & Company LLCInitiated CoverageBuy$12.00Low
9/24/2021William BlairInitiated CoverageOutperformMedium
9/13/2021CowenInitiated CoverageOutperform$20.00Medium
(Data available from 5/26/2017 forward)

News Sentiment Rating

0.29 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 4 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/28/2021
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/27/2021
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/27/2021
  • 7 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
1/26/2022
  • 5 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/25/2022
  • 3 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
3/27/2022
  • 2 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/26/2022
  • 3 very positive mentions
  • 9 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
5/26/2022

Current Sentiment

  • 3 very positive mentions
  • 9 positive mentions
  • 3 negative mentions
  • 0 very negative mentions
Cellebrite DI logo
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, intellectual property theft, and civil litigation. The company's Universal Forensic Extraction Device solution addresses problems in accessing digital information, including complicated device locks, encryption barriers, deleted and unknown content, and other obstacles that can prevent critical evidence from coming to light. It also offers Seeker solution that provides the ability to analyze video footage; OSINT Analyze, a real-time deep dive solution used to analyze open-source information, such as the surface web, deep web, and the dark web; and Crypto Tracer, which analyzes blockchain transactions together with related data from an extensive list of sources to identify and categorize wallets, and transactions. The company serves federal and state and local agencies, as well as enterprise companies and service providers. It has operations in the United States, Germany, Singapore, Australia, Brazil, United Kingdom, France, Canada, Japan, and India. The company was incorporated in 1999 and is based in Petah Tikva, Israel. Cellebrite Mobile Synchronization Ltd. operates as a subsidiary of Sun Corporation.
Read More

Today's Range

Now: $4.56
Low: $4.44
High: $4.71

50 Day Range

MA: $5.64
Low: $4.49
High: $7.32

52 Week Range

Now: $4.56
Low: $4.10
High: $13.24

Volume

157,080 shs

Average Volume

291,757 shs

Market Capitalization

$859.74 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.57

Frequently Asked Questions

What sell-side analysts currently cover shares of Cellebrite DI?

The following equities research analysts have issued stock ratings on Cellebrite DI in the last twelve months: Bank of America Co., Citigroup Inc., Cowen Inc, Deutsche Bank Aktiengesellschaft, JPMorgan Chase & Co., Needham & Company LLC, William Blair, and Zacks Investment Research.
View the latest analyst ratings for CLBT.

What is the current price target for Cellebrite DI?

0 Wall Street analysts have set twelve-month price targets for Cellebrite DI in the last year. Their average twelve-month price target is $11.50, suggesting a possible upside of 152.2%.
View the latest price targets for CLBT.

What is the current consensus analyst rating for Cellebrite DI?

Cellebrite DI currently has 7 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe CLBT will outperform the market and that investors should add to their positions of Cellebrite DI.
View the latest ratings for CLBT.

What other companies compete with Cellebrite DI?

How do I contact Cellebrite DI's investor relations team?

Cellebrite DI's physical mailing address is Four Embarcadero Center Suite 2100, SAN FRANCISCO CA, 94111. The company's listed phone number is 415-780-9981 and its investor relations email address is [email protected] The official website for Cellebrite DI is www.cellebrite.com. Learn More about contacing Cellebrite DI investor relations.